The Congressional Academic Medicine Caucus and the Association of American Medical Colleges today sponsored a Capitol Hill briefing to highlight the urgent nationwide need for more physicians to treat substance use disorders. In calling for passage of the AHA-supported Opioid Workforce Act (H.R. 3414/S.2892), the briefing featured remarks from Reps. Brad Schneider, D-Ill., and Susan Brooks, R-Ind., the bill’s lead House sponsors, and Rep. Phil Roe (R-TN), a member of the Energy and Commerce Committee. Panelists included Bradley Allen, M.D., of the Indiana University School of Medicine; Scott Teitelbaum, M.D., of the American Society of Addiction Medicine; and Barbara Allen, executive director of James’ Place, a Maryland-based advocacy group that promotes greater access to care. 

Related News Articles

Headline
AHA March 26 submitted comments on a discussion draft of the SUSTAIN 340B Act, legislation proposed in the Senate to clarify Congress’ intent in creating the…
Headline
President Biden March 24 signed legislation funding the rest of the federal government through Sept. 30, including Department of Health and Human Services…
Headline
States can apply through May 20 for up to $2 million to partner with communities to integrate primary and behavioral health care in clinical practices and $900…
Headline
The House March 22 voted 286-134 to pass the Further Consolidated Appropriations Act of 2024, legislation that would fund all remaining federal agencies…
Headline
A new AHA Resource Snapshot highlights training and other resources to help hospital leaders strengthen and support workforce well-being.  
Headline
The House and Senate Appropriations committees March 20 released the Further Consolidated Appropriations Act of 2024, legislation that would fund all remaining…